glp-1 diarrhea class action in michigan A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly's blockbuster drug to treat obesity. When the major pharmacy benefit manager informed patients Managing GLP-1 therapy side effects
Pay in 4 interest-free payments of $7.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


























